PMS Support
Natural health product licensed in Canada
- Other names
- Future Nutrition PMS Support
- Licence holder
- Konsar Future Nutrition Inc.
- NPN or DIN-HM
- 80063048
- Status
- Inactive licence
- Licence date
- 29 July 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 140 mg a day according to the dosing instructions published by Health Canada (14 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 140 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine Source : Riboflavine | 10 mg | 140,000 µg |
| Niacinamide Source : Niacinamide | 10 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 10 mg | 140,000 µg |
| Choline Source : Bitartrate de choline | 10 mg | Not calculated |
| Inositol Source : Inositol | 10 mg | Not calculated |
| Folate Source : Acide folique | 40 mcg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 10 mcg | 140 µg |
| Biotine Source : Biotine | 10 mcg | 140 µg |
| Thiamine Source : Mononitrate de thiamine | 10 mg | 140,000 µg |
| Vitex agnus-castus Source : Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Actaea racemosa Source : Racine et rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg | 150 mg | Not calculated |
| Extrait d'isoflavone de soja Source : Glycine max - Graine Potency : 40 % Isoflavones | 100 mg | Not calculated |
| Oryza sativa Source : Enveloppe Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 3,000 mg Potency : 98 % gamma-Oryzanol | 100 mg | Not calculated |
| Hypericum perforatum Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg Potency : 3 % Hypericin | 100 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Foeniculum vulgare subsp. vulgare var. vulgare - Seed Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 1,000 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 14 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help the pain associated with menstruation. Used in Herbal Medicine to help ease nervous tension, and relieve restlessness or nervousness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80063048
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.